Bariatric surgery decreases prescription drug costs for metabolic syndrome: a Canadian population-based cohort study

Hayley Forbes,Wenjing He,Isuru Dharmasena,Heather J. Prior,Ashley Vergis,Krista Hardy
DOI: https://doi.org/10.1007/s00464-024-11144-8
2024-10-02
Surgical Endoscopy
Abstract:Obesity is a chronic disease that is significantly linked to metabolic syndrome. Bariatric surgery is considered the most effective treatment for obesity resulting in long-term weight loss and comorbidity resolution. Prior studies have demonstrated the overall cost effectiveness of bariatric surgery; however, there is little data regarding direct pharmaceutical costs. The objective of this population-based study is to compare the cost of dispensed common prescription medications for metabolic syndrome before and after bariatric surgery.
surgery
What problem does this paper attempt to address?